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MBS496   Like MBS164 only RTT107‐6XHIS‐3XFLAG::KanMX6 KanMX6∆::LEU2  SMC6‐6xHis‐3xHA::KanMX6  MBS509   Like MBS164 only DPB11‐6XHIS‐3XFLAG::KanMX6 KanMX6∆::LEU2  RTT107‐6xHis‐3xHA::KanMX6  MBS542   Like MBS164 only DPB11‐6XHIS‐3XFLAG::KanMX6 KanMX6∆::LEU2 SLX1‐6xHis‐3xHA::KanMx6  MBS569   Like MBS164 only DPB11‐6XHIS‐3XFLAG::KanMX6 KanMX6∆::LEU2 SLX1‐6xHis‐3xHA::KanMx7 rtt107∆::URA3  MBS571   Like MBS164 only DPB11‐6xHis‐3xHA::KanMX6 KanMX6∆::LEU2 SLX4‐6XHIS‐3XFLAG::KanMX6  MBS573   Like MBS164 only DPB11‐6xHis‐3xHA::KanMX6 KanMX6∆::LEU2 SLX4‐6XHIS‐3XFLAG::KanMX6 rtt107∆::URA3  MBS579   Like MBS164 only DPB11‐6xHis‐3xHA::KanMX6 KanMX6∆::LEU2 slx4∆::KanMX6  MBS621  Like MBS164 only DPB11‐6xHis‐3xHA::KanMX6 KanMX6∆::LEU2 SLX4‐6XHIS‐3XFLAG::KanMX6 slx1∆::URA  MBS628   Like MBS164 only slx4∆::URA3 ura3∆::SLX4‐6XHIS‐3XFLAG KanMX6  






































Look for the specfic interactors identified in experiment A
Mec1-independent
Ratio H/L ~ 1.0
mec1! cells 
with Rtt107-HA































































Rtt107-Flag      -     -     +      +          -     -     +    +  
MMS      -     +      -      +          -    +     -     +     










Dpb11-Flag      -       -     +      +         -     -      +     +  
























































































































































Figure S1 (related to Figure 3): (A) Slx4 is still phosphorylated upon MMS treatment in 
rtt107! cells, but to a lesser extent. Indicated cells expressing Slx4-Flag were treated with 
0.04% MMS for 2 hours. Immunoblot was probed with anti-Flag antibody. (B) Slx1 physically 
interacts with Dpb11; and (C) Slx1 is not important for the interaction between Slx4 and 
Dpb11. (B and C) Cells with the indicated epitope-tagged proteins were treated with 0.04% MMS 
for 2 hrs. Protein extracts were immunoprecipitated with anti-Flag agarose resin and immunoblots 



























Figure S2 (related to Figure 4): (A) SLX4-7MUT still interacts with Slx1. Cells with the 
indicated epitope-tagged proteins were treated with 0.04% MMS for 2 hours. Protein extracts 
were immunoprecipitated with anti-Flag agarose resin and immunoblots were probed with anti-HA 
or anti-Flag antibodies. *: contaminating band. (B) Mutation of all 10 SQ/TQ motifs (10AQ) in 
Rtt107 does not lead to MMS sensitivity. Sensitivity of rtt107! cells expressing the indicated 
constructs. Four fold serial dilutions were spotted on plates and grown for 2 days at 30"C. 
4BRCT-mut contains point mutations in four conserved tryptophan residues (mutated to 
phenylalanine) in the four n-terminal BRCT domains of Rtt107. (C) Slx4 interacts with Dpb11 
following Orc6 phosphorylation. Cells expressing Slx4-Flag, Dpb11-HA and Orc6-HA were 
arrested in G1 and released in 0.04% MMS for the indicated time. For the Slx4-IP, protein 
extracts were immunoprecipitated with anti-Flag agarose resin and immunoblots were probed 
























































































arg4∆, sml1∆:TRP1, bar1∆:HIS3, slx4∆:URA3 MBS626  MATa, ura3­52, trp1­63, his3­200, bar1∆:HIS3 MBS943 = yDD_705 (W303)  MATa ade2­1 trp1­1 can1­100 leu2­3, 112 his3­11, 15 ura3­1 GAL+ psi+ ssd1­d2 RAD5+  MBS944 = yDD_1793 (W303)  MATa hta1­S129A hta2­S129A leu2­3, 112 his3­11, 15 ade2­1 ura3­1 trp1­1 can1­100 RAD5+  MBS957 (W303)  MATa ade2­1 trp1­1 can1­100 leu2­3, 112 his3­11, 15 ura3­1 GAL+ psi+ ssd1­d2 RAD5+, rtt107∆:HIS3 MBS958 (W303)  MATa hta1­S129A hta2­S129A leu2­3, 112 his3­11, 15 ade2­1 ura3­1 trp1­1 can1­100 RAD5+, rtt107∆:HIS3  
  95 

























slx4∆:HIS3 (Spore) MBS1448 (W303)  MATa  hta1­S129A  hta2­S129A  leu2­3,  112  his3­11,  15  ade2­1  ura3­1    trp1­1 can1­100 RAD5+, RAD53_6xHis­3xHA::KanMX6 MBS1452  MATa, ura3­52, trp1­63, his3­200, RAD53_6xHis­3xFLAG::KanMX6, bar1∆:URA3 MBS1453  MATa, ura3­52, trp1­63, his3­200, RAD53_6xHis­3xFLAG::KanMX6::KanMX6, 
slx4∆:HIS3, bar1∆:URA3 MBS1454  MATa, ura3­52, trp1­63, his3­200, rad53­R605A_ 6xHis­3xFLAG::KanMX6, 
bar1∆:URA3 MBS1464  MATa, ura3­52, trp1­63, his3­200, rad53­R605A_ 6xHis­3xFLAG::KanMX6, 









































Vector  Gene  Mutation  Tag 
pMBS32  = 
HZE1210 
pFA6a  RAD53  ‐  ‐ 
pMBS38  = 
HZE1267 
pFA6a  RAD53  ‐  FLAG 
pMBS39  = 
HZE1268 
pFA6a  rad53  R70A  FLAG 
pMBS40  = 
HZE1269 
pFA6a  rad53  R605A  FLAG 
pMBS65  pYES2/NT C  ‐  ‐  HA 
pMBS148  pRS416  ‐  ‐  ‐ 
pMBS163  pRS416  RTT107  ‐  HA 
pMBS166  pYES‐ntc  RTT107  ‐  HA 
pMBS175  pFA6a  RAD9  ‐  HA 
pMBS197  pYES2/NT C  RTT107(aa818‐1070)  ‐  HA 
pMBS218  pFA6a  SLX4  ‐  FLAG 




pMBS249  pET21a  RTT107(aa750‐1070)  ‐  PATH 
pMBS250  pET21a  rtt107(aa750‐1070)   R884E  PATH 
pMBS261  pRS416  rtt107  R884E  HA 
pMBS297  pET21a  DPB11(aa1‐270)  ‐  PATH 
pMBS298  pET21a  DPB11(aa271‐582)  ‐  PATH 
pMBS327  pFA6a  slx4  S486A  FLAG 
pMBS340  pFA6a   
   
slx4  T457A, T474A, S499A, 
T597A, S627A, S659A, 
S725A, S486A 
FLAG 
pMBS349  pFA6a  rad9  K1088M  HA 
pMBS362  pFA6a  rad53  R605A  ‐ 
pMBS375  pYES2/NT C  rtt107(aa818‐1070)   R884E  HA 
pMBS401  pRS416  pADH1‐SLX4*  ‐  Myc 
pMBS402  pRS416  pTDH3‐SLX4*  ‐  Myc 
pMBS406  pRS416  pTDH3‐slx4*  S486A  Myc 
pMBS414  pRS416  pADH1‐DPB11*  ‐  HA 
pMBS435  pFA6a    pADH1‐SLX4*  ‐  Myc 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Supplementary Figure 2. Rad53 activation in slx4!  cells is Rad9-dependent. Western blot 
showing the phosphorylation status of Rad53-HA in indicated strains. Cells were arrested in G1 




















































Supplementary Figure 3. Rad53 hyperactivation and FHA2 mutation-dependent 
phenotypic rescue in slx4!  cells carrying untagged RAD53 alleles. a, Cells lacking SLX4 
and carrying an untagged allele of RAD53 also exhibit MMS-induced hyperactivation of Rad53. 
Rad53 was detected using anti-Rad53 antibody from Santa Cruz (yc-19, cat. # sc-6749). b, 
The MMS-sensitivity of cells lacking SLX4 and carrying an untagged allele of RAD53 can also 
be rescued by a disrupting mutation in the FHA2 domain of Rad53 (R605A). All of the indicated 























Supplementary Figure 4. Slx4 has an Slx1 and Rad1-independent function. a, MMS 
sensitivity assay of the indicated strains. b, Western blot for Rad53 phospho-status. Cells were 


















Supplementary Figure 5. Co-immunoprecipitation between Dpb11 and Rad9 in wild-type 
and slx4! cells. Asterisk indicates a contaminating band that is specifically present in 
















Supplementary Figure 6. Manual alignment of the Dpb11-binding region of Sld3 with 
amino acids 457-500 of Slx4. Proline-directed and Mec1 consensus phosphorylation sites are 
indicated in dark and light boxes, respectively. Numbers indicate the amino acid position in 


















Supplementary Figure 7. Manual alignment of proline-directed sites in Slx4, Rad9 and 
Sld3 important for binding to Dpb11. Blue boxes indicate the residues that have been shown 
to be important for Dpb11 interaction with Sld319,20, Rad917,18 and Slx4 (this study).  Red shade 





























Supplementary Figure 8. Overexpression of Slx4 reduces Rad53 activation. Rad53 
phospho-status in (a) wild-type and (b) dot1! cells expressing Slx4 from its endogenous 
promoter or overexpressing Slx4 from a plasmid under the control of a TDH3 promoter. (c) 
Rad53 phospho-status in wild-type and dot1! cells expressing Slx4 from its endogenous 
promoter or overexpressing Slx4 from an ADH1 promoter integrated in the genome, which 
replaced the endogenous SLX4 promoter. The experiment in (c) was performed in YPD media 






























































































































































































































































































arg4∆, sml1∆:TRP1, bar1∆:HIS3, Slx4_6xHis­3xFLAG::KanMX6 MBS640  ura3­52, trp1­63, his3­200 MBS903  MATa_ura3­52, trp1­63, his3­200 MBS904  MATa_ura3­52, trp1­63, his3­200, slx4∆:HIS3 MBS1780  MATa, ura3­52, leu2∆1, trp1∆63, his3∆200, lys2∆Bgl, hom3­10, ade2∆1, ade8, 
arg4∆, sml1∆:TRP1, bar1∆:HIS3, RAD53_6xHis­3xHA::NatMX4, rad9 S462A, 








Vector  Gene  Mutation  Tag 
pMBS148  pRS416  ‐  ‐  ‐ 
pMBS399  pFA6a  rad9  S462A, S474A  HA 
pMBS414  pRS416  pADH1‐DPB11*  ‐  HA 
pMBS433  pRS416  pADH1‐DPB11*  ‐  FLAG 






pADH1‐slx4*  T457A, T474A, S499A, 
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Figure A.4. Co‐overexpression of Slx4 with Dpb11 reduces the MMS sensitivity and excessive Rad53 activation resulting form Dpb11 overexpression. (a) MMS sensitivity of Dpb11 overexpressing cells in Wt or slx4­7MUT background. Four‐fold serial dilutions were spotted on plates and grown for 2–3 days at 30°C. (b) Western blot analysis showing the phosphorylation status of HA tagged Rad53 in Dpb11 overexpressing or Dpb11 and Slx4 co‐overexpressing cells. C‐terminal FLAG tagged Dpb11 was expressed ectopically under the control of the ADH1 promoter. C‐terminal Myc tagged Slx4 or slx4­7MUT were overexpressed from the SLX4 endogenous locus under the control of the ADH1 promoter. 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